News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,750 Results
Type
Article (318)
Company Profile (1)
Press Release (6431)
Section
Business (2127)
Career Advice (3)
Deals (273)
Drug Delivery (1)
Drug Development (923)
Employer Resources (2)
FDA (222)
Job Trends (99)
News (3522)
Policy (234)
Tag
Academia (27)
Allergies (1)
Alliances (681)
ALS (1)
Alzheimer's disease (6)
Approvals (226)
Artificial intelligence (8)
Autoimmune disease (1)
Bankruptcy (2)
Best Places to Work (81)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (1)
Brain cancer (1)
Breast cancer (4)
Cancer (57)
Cardiovascular disease (2)
Career advice (3)
CAR-T (4)
Cell therapy (8)
Clinical research (802)
Collaboration (16)
Compensation (3)
Complete response letters (2)
COVID-19 (41)
C-suite (6)
Cystic fibrosis (1)
Data (43)
Depression (2)
Diagnostics (64)
Drug discovery (4)
Drug pricing (1)
Earnings (597)
Editorial (1)
Employer resources (2)
Events (1115)
Executive appointments (7)
FDA (239)
Funding (8)
Generative AI (1)
Gene therapy (1)
GLP-1 (4)
Government (26)
Guidances (2)
Healthcare (122)
Immunology and inflammation (1)
Infectious disease (41)
Intellectual property (1)
IPO (87)
Job creations (21)
Job search strategy (3)
Labor market (1)
Layoffs (6)
Legal (42)
Liver cancer (1)
Lung cancer (10)
Lymphoma (10)
Management (2)
Manufacturing (5)
MASH (15)
Medical device (142)
Medtech (143)
Mergers & acquisitions (193)
Metabolic disorders (16)
NASH (2)
Neurodegenerative disease (2)
Neuroscience (12)
NextGen: Class of 2026 (38)
Non-profit (26)
Obesity (1)
Opinion (1)
Partnered (1)
Patents (4)
Patient recruitment (5)
People (804)
Phase 1 (215)
Phase 2 (383)
Phase 3 (303)
Pipeline (39)
Postmarket research (29)
Preclinical (79)
Prostate cancer (6)
Radiopharmaceuticals (5)
Rare diseases (2)
Real estate (49)
Regulatory (200)
Research institute (33)
Schizophrenia (1)
Series A (2)
Series B (1)
Startups (48)
Vaccines (7)
Date
Last 7 days (1)
Last 30 days (10)
Last 365 days (205)
2026 (17)
2025 (215)
2024 (274)
2023 (309)
2022 (406)
2021 (402)
2020 (354)
2019 (383)
2018 (397)
2017 (532)
2016 (411)
2015 (475)
2014 (290)
2013 (278)
2012 (298)
2011 (280)
2010 (239)
Location
Africa (4)
Asia (267)
Australia (39)
California (28)
Canada (47)
China (4)
Colorado (5)
Connecticut (1)
Europe (2521)
Florida (3)
Illinois (3)
Japan (3)
Massachusetts (56)
Minnesota (41)
Missouri (5)
New Jersey (12)
New York (58)
North Carolina (4)
Northern California (8)
Ohio (1)
Pennsylvania (2)
South America (21)
South Carolina (2)
Southern California (14)
Texas (3)
United States (225)
Utah (2)
Washington State (1)
6,750 Results for "pierre fabre medicament".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
January 9, 2026
·
6 min read
Press Releases
PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION
January 12, 2026
·
4 min read
Press Releases
Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month
September 30, 2025
·
2 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
December 8, 2025
·
7 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
November 3, 2025
·
5 min read
Press Releases
Pierre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
Press Releases
Pierre Fabre USA Unites with Breast Cancer Alliance to Advance Breast Cancer Surgery
May 20, 2025
·
5 min read
Press Releases
Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
June 16, 2025
·
2 min read
Press Releases
Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
July 25, 2025
·
4 min read
Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome
Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome.
April 26, 2024
·
4 min read
1 of 675
Next
